0.3503
전일 마감가:
$0.3401
열려 있는:
$0.3301
하루 거래량:
628.57K
Relative Volume:
0.60
시가총액:
$27.50M
수익:
$4.17M
순이익/손실:
$-27.71M
주가수익비율:
-0.9468
EPS:
-0.37
순현금흐름:
$-22.23M
1주 성능:
-9.58%
1개월 성능:
-15.61%
6개월 성능:
-56.21%
1년 성능:
-63.51%
Clearside Biomedical Inc Stock (CLSD) Company Profile
명칭
Clearside Biomedical Inc
전화
678-270-3631
주소
900 NORTH POINT PARKWAY, ALPHARETTA, GA
CLSD을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CLSD
Clearside Biomedical Inc
|
0.3503 | 26.62M | 4.17M | -27.71M | -22.23M | -0.37 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-18 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
2025-07-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2025-07-18 | 다운그레이드 | Stifel | Buy → Hold |
2024-08-21 | 개시 | Chardan Capital Markets | Buy |
2024-06-25 | 개시 | Oppenheimer | Outperform |
2021-12-15 | 재개 | Wedbush | Outperform |
2021-07-29 | 개시 | H.C. Wainwright | Buy |
2020-05-13 | 개시 | ROTH Capital | Buy |
2019-08-09 | 다운그레이드 | Needham | Buy → Hold |
2018-11-05 | 다운그레이드 | Cowen | Outperform → Market Perform |
2018-11-05 | 다운그레이드 | JP Morgan | Overweight → Underweight |
2018-11-05 | 다운그레이드 | Stifel | Buy → Hold |
2018-03-06 | 재확인 | Needham | Buy |
2017-05-25 | 개시 | JMP Securities | Mkt Outperform |
2017-02-24 | 개시 | JP Morgan | Overweight |
2016-11-10 | 재확인 | Needham | Buy |
2016-10-24 | 재확인 | Stifel | Buy |
모두보기
Clearside Biomedical Inc 주식(CLSD)의 최신 뉴스
Published on: 2025-09-04 03:06:19 - Newser
Clearside Biomedical Approves Reverse Stock Split Proposal - TipRanks
What momentum shifts mean for Clearside Biomedical Inc.Earnings Risk Report & Fast Gain Stock Tips - Newser
Building trade automation scripts for Clearside Biomedical Inc.July 2025 Levels & Risk Managed Investment Signals - Newser
Understanding Clearside Biomedical Inc.’s price movement2025 Historical Comparison & Risk Controlled Stock Pick Alerts - Newser
Tick level data insight on Clearside Biomedical Inc. volatilityPrice Action & Stock Market Timing Techniques - Newser
Analyzing net buyer seller activity in Clearside Biomedical Inc.New Guidance & Real-Time Market Trend Scan - Newser
Can volume confirm reversal in Clearside Biomedical Inc.Dollar Strength & High Conviction Investment Ideas - Newser
Live market analysis of Clearside Biomedical Inc.2025 Key Highlights & Weekly Setup with ROI Potential - Newser
Clearside Biomedical Inc. stock prediction for this weekQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Using AI based signals to follow Clearside Biomedical Inc.Market Growth Summary & Weekly Top Gainers Trade List - Newser
Applying big data sentiment scoring on Clearside Biomedical Inc.Exit Point & High Win Rate Trade Alerts - Newser
Backtesting results for Clearside Biomedical Inc. trading strategies - Newser
Clearside Biomedical Inc. stock trend outlook and recovery pathJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser
Is Clearside Biomedical Inc. stock reversal real or fakePortfolio Return Report & Detailed Earnings Play Alerts - Newser
Should I hold or sell Clearside Biomedical Inc. nowJuly 2025 Patterns & Real-Time Buy Signal Alerts - khodrobank.com
Can Clearside Biomedical Inc. generate free cash flowJuly 2025 Chart Watch & High Accuracy Trade Signal Alerts - khodrobank.com
Is Clearside Biomedical Inc.’s ROIC above industry average2025 Price Momentum & Smart Investment Allocation Insights - khodrobank.com
Should value investors consider Clearside Biomedical Inc.CPI Data & Breakout Confirmation Trade Signals - khodrobank.com
Does Clearside Biomedical Inc. outperform in volatile marketsJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - khodrobank.com
Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery - MSN
Clearside Biomedical Inc. stock outlook for YEARWeekly Trade Analysis & Consistent Income Trade Recommendations - Newser
Measuring Clearside Biomedical Inc.’s beta against major indices2025 Volume Leaders & High Conviction Investment Ideas - Newser
What institutions are buying Clearside Biomedical Inc. stock nowPortfolio Growth Summary & Smart Money Movement Tracker - Newser
Using portfolio simulators with Clearside Biomedical Inc. includedWeekly Trend Summary & Long-Term Capital Growth Ideas - Newser
Custom strategy builders for tracking Clearside Biomedical Inc.Quarterly Trade Review & High Accuracy Trade Alerts - Newser
Is Clearside Biomedical Inc. affected by consumer sentimentQuarterly Risk Review & Real-Time Stock Price Movement Reports - theviewers.co.kr
Can Clearside Biomedical Inc. Regain Lost Ground This Quarter2025 Key Lessons & Fast Entry Momentum Alerts - beatles.ru
What are analysts’ price targets for Clearside Biomedical Inc.Market Performance Summary & Real-Time Chart Pattern Alerts - 한국정경신문
Is Clearside Biomedical Inc. trending in predictive chart modelsEarnings Overview Report & Comprehensive Market Scan Insights - Newser
Sentiment Turns Positive on Clearside Biomedical Inc. — Reversal Ahead getLinesFromResByArray error: size == 0 - thegnnews.com
Clearside Biomedical Posts Q2 2025 Earnings Miss; Market Reaction Signals Investor Caution - AInvest
Intraday pattern recognizer results for Clearside Biomedical Inc.2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
Combining machine learning predictions for Clearside Biomedical Inc.Weekly Trade Report & Weekly Breakout Watchlists - Newser
Clearside Biomedical Inc (CLSD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clearside Biomedical Inc 주식 (CLSD) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Chong Ngai Hang Victor | Chief Medical Officer |
Nov 01 '24 |
Buy |
1.00 |
36,500 |
36,500 |
100,000 |
자본화:
|
볼륨(24시간):